DANNY CHOU

Danny Chou was born in I-lan, Taiwan and received his bachelor degree in Chemistry from National Taiwan University in 2006. From 2003 to 2006, he worked under the supervision of Prof. Ken-Tsung Wong and received trainings in organic synthesis. After a year of mandatory military service, he attended graduate school at Harvard University, working in the lab of Prof. Stuart Schreiber. His Ph.D. research involved the identification of suppressors of cytokine-induced apoptosis in pancreatic beta cells. He then moved to MIT, where he was a JDRF Postdoctoral Fellow in Department of Chemical Engineering. He worked under the guidance of Profs. Robert Langer and Daniel Anderson, focusing on the development of glucose-responsive insulin derivatives. Danny started his independent career in Department of Biochemistry at University of Utah in August, 2014. At Utah, Danny's research focuses on protein and peptide therapeutics for the treatment in Type 1 Diabetes and other human diseases.